Navigation Links
Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
Date:3/17/2008

nts; we may not be able to establish marketing and sales capabilities and the costs of launching our products may be greater than anticipated; we rely on third parties for the continued supply and manufacture of vernakalant (iv) and vernakalant (oral) and we have no experience in commercial manufacturing; we may face unknown risks related to intellectual property matters; we face increased competition from pharmaceutical and biotechnology companies; and other factors as described in detail in our filings with the Securities and Exchange Commission available at http://www.sec.gov and the Canadian securities regulatory authorities at http://www.sedar.com. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements and information, which are qualified in their entirety by this cautionary statement. All forward-looking statements and information made herein are based on our current expectations and we undertake no obligation to revise or update such forward-looking statements and information to reflect subsequent events or circumstances, except as required by law.

CONTACT: Peter K. Hofman, Senior Director, Investor Relations, (604) 676-6993 or Toll Free: 1-800-330-9928, Email: phofman@cardiome.com


'/>"/>
SOURCE Cardiome Pharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Cardiome And Astellas Announce Regulatory Update
2. Cardiome to Hold Investor Update Call
3. Cardiome Updates Guidance
4. Cardiome Initiates Phase 1 Study for GED-aPC
5. Cardiome To Release Third Quarter Results
6. Cardiome to Present at CIBC Conference
7. Cardiome to Present at ThinkEquity Conference
8. Cardiome to Present at Bear Stearns Conference
9. Weight Watchers Announces Election of Kim Roy to Board of Directors
10. MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation
11. Exelixis Announces March 19 Webcast of Presentation at the Lehman Brothers Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Plano, Texas (PRWEB) October 22, 2014 ... convenience of completing their continuing education at home ... now have access to 20 brand new, premium ... HomeCEUConnection.com’s robust catalog of over 2,000 hours ... to fully customize their educational experience. With such ...
(Date:10/22/2014)... Lintelus, Inc., an event software provider, announced ... will be speaking on the subject of “Event Technology ... 28, at the Holiday Inn in New York City. ... as a Tech Demo at 12:45pm, to educate event ... engaging event experience. , The Annual Meetings Technology Expo ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... may be showing a genetic propensity for obesity as toddlers, ... been linked to increased body fat, but the same genes ... the researchers said. At 1 year, kids with these ... 3, however, these genes were linked to excessive weight gain, ...
(Date:10/22/2014)... Tara Haelle HealthDay Reporter ... among young adult men may lead to increased blood pressure, ... cause a similar rise in blood pressure for young adult ... when young adult women drank lightly or moderately, their risk ... found. "This finding parallels studies in older adult men ...
(Date:10/22/2014)... By Dennis Thompson ... -- U.S. health officials on Monday officially tightened guidelines for ... with no skin exposure and use of a respirator at ... Prevention decided to issue the tougher rules after two Dallas ... diagnosed in the United States, Liberian national Thomas Eric Duncan. ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3
... Celebrate you" health fair will provide free, health screenings ... WICHITA, Kan., July 30 As summer vacation slowly ... the return to school.,Getting ready to go back to ... To help parents, the "Celebrate,Your Children, Celebrate You," health ...
... treated for breast cancer did not know that their odds ... whether they undergo mastectomy or breast conserving surgery. Minority women ... factor of their treatment decision, according to a study from ... were also less likely to know about relative survival rates ...
... July 30 Dyadem today announced that ... Hofliger, a Germany-based builder of,production equipment for ... FMEA-Med software to help its customers minimize ... of its specialized,pharmaceutical equipment., Harro Hofliger ...
... conjunction,with DURECT Corporation,s (Nasdaq: DRRX ) second ... to listen to the conference call,that will be ... 6, 2008,at 9:00 a.m. EDT (6:00 a.m. PDT)., ... audio webcast of the presentation will be available ...
... Joins Premier Professional Online Medical Resource as ... ... The Doctor,s Channel, (http://www.thedoctorschannel.com ), today announced the appointment of ... Contributing Editor. Hailed by CNBC as the "educational,YouTube" for doctors, ...
... of Love Canal Are Not Counted In the NY State,Department ... What Have We Learned?, FALLS CHURCH, Va., July 30 ... Environment & Justice:, WHAT:, Press Conference & walking ... once stood., Rain or Shine, WHEN:, Friday, ...
Cached Medicine News:Health News:UniCare Health Plan Teams With Local Organizations for Community and Wellness Fair 2Health News:Minorities less likely to know about breast cancer treatment options 2Health News:Minorities less likely to know about breast cancer treatment options 3Health News:Harro Hofliger Reduces Risk in Pharmaceutical Manufacturing Equipment with Dyadem 2Health News:Harro Hofliger Reduces Risk in Pharmaceutical Manufacturing Equipment with Dyadem 3Health News:DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call 2Health News:The Doctor's Channel Adds Esteemed Director of Minimally Invasive Urology at Columbia University to Editorial Team 2Health News:The Doctor's Channel Adds Esteemed Director of Minimally Invasive Urology at Columbia University to Editorial Team 3Health News:30 Years After State of Emergency Declared at Love Canal, NY Closing the 99th Street School Triggering the Federal Superfund Program; Schools & Communities Across the Nation Still at Risk of Toxic Contamination 2
(Date:10/22/2014)... AUSTIN, Texas , Oct. 22, 2014 ... announced they have entered into a license and ... to target cancers. PhosImmune possesses technology ... the surfaces of tumor cells in association with ... from proteins that play a role in malignancy, ...
(Date:10/22/2014)... SHANGHAI , Oct. 22, 2014 /PRNewswire/ ... FMI ) and WuXi PharmaTech (Cayman) Inc. (NYSE: ... Foundation Medicine,s comprehensive genomic profiling to biopharmaceutical companies conducting ... Under the terms of the collaboration, Foundation ... laboratory component of Foundation Medicine,s FoundationOne® assay at the ...
(Date:10/20/2014)... DIEGO , Oct. 20, 2014  ResMed ... availability of the ResMed Data Exchange program, a ... home medical equipment (HME) and other health care ... timely, secure access to critical patient information. It ... ResMed,s AirView™ and U-Sleep™ patient management platforms with ...
Breaking Medicine Technology:Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 3Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 4Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 5ResMed Launches ResMed Data Exchange 2
... , RICHMOND, Va., Nov. 4 Filtrona Porous Technologies, ... for the medical device and healthcare industry, and a ... recently developed a unique foam-fiber hybrid component for select ... Referred to as MediSponge® RBR , the patent-pending ...
... Therapeutics, Inc. (OTC Bulletin Board: ECTE), a diabetes management ... non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and ... today that it has initiated a clinical study of ... in patients with Type 1 and Type 2 diabetes. ...
Cached Medicine Technology:Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings 2Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 2Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 3
...
... steel construction for lifelong quality. Sealed hydraulic ... chair movement. Soft, contoured cushions with heavy-duty ... counter-balanced slit lamp arm for easy, smooth, ... slit lamp arm for easy access to ...
Our Ophthalmic Diagnostic Sets offer everything an eye care specialist needs. Complete your set with your choice of ophthalmoscope, retinoscope, handle, and case....
3.5v Coaxial Ophthalmoscope Set with Convertible Handle and Hard Case. Our 3.5v Coaxial Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Medicine Products: